| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.62 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |